Metraipolis › archive › dc_3568ae682f01

Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin) — Europe PMC PMID:41900869

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41900869
DOI
10.3390/pharmaceutics18030383
License (as archived)
solo-consultazione
Archived
2026-11-04T04:31:43.078Z
SHA-256 of the archived text
40caf86f84ca044f958cafca93d99fd0e04444920265383687b507a5379473c1
Stable URL of this page
https://metraipolis.com/documento/dc_3568ae682f01

How to cite

Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin) — Europe PMC PMID:41900869 — Europe PMC (en), https://europepmc.org/article/MED/41900869 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3568ae682f01 (Metraipolis archive dc_3568ae682f01, sha256 40caf86f84ca044f958cafca93d99fd0e04444920265383687b507a5379473c1)
BibTeX
@misc{dc3568ae682f01,
  title = {Analytical Physicochemical and Functional Studies to Compare AryoTrust, a Follow-On Biologics, with the Originator Trastuzumab (Herceptin) — Europe PMC PMID:41900869},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41900869},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3568ae682f01; sha256 40caf86f84ca044f958cafca93d99fd0e04444920265383687b507a5379473c1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41900869. Agents can read the archived copy with the MCP tool read_document.